Amplity Health Unveils AI-Driven Survey Platform, Revolutionizing Early Drug Launch Insights

In a groundbreaking move, Contract Medical and Commercial Organization, Amplity Health, has introduced a pioneering AI-driven solution named Survey by AskX. This transformative platform offers pharmaceutical and biopharmaceutical companies unprecedented field insights during the critical early days of a drug’s release.

The first six weeks post-launch are deemed crucial for a drug’s future market performance. Traditional survey methods and data collection practices often hinder informed action during this vital period, marked by clunky language and delayed response times. Recognizing this challenge, Amplity Health’s Survey by AskX platform leverages AI-powered capabilities to address these shortcomings.

This first-of-its-kind platform enables leadership to create customized field surveys using free-text responses, employing advanced generative AI. The Survey by AskX environment is entirely free-text based, allowing leaders to construct surveys and interpret results in plain language, eliminating the need for additional time and personnel to make sense of survey findings. This marks a significant enhancement in the consistency, timeliness, and value of field insights.

Joe Turner, Head of Amplity Insights, highlighted the platform’s unique ability to compliantly record discussions between field representatives and clinicians in free-text. Survey by AskX utilizes AI-powered compliance reviews to flag reportable issues, providing data that is as accessible as a casual conversation over coffee.

Survey by AskX promises the most up-to-date and easy-to-understand insights for ensuring launch excellence, without the historical challenges associated with data science lift and compliance concerns. Industry stakeholders are already hailing the platform as a game-changer, emphasizing its speed, accuracy, and clear, concise takeaways.

While still in its early stages, Survey by AskX has garnered praise for suggesting mid-course corrections and offering both microscopic and high-altitude views of the playing field. A top pharma leader reported the platform’s immediate ability to provide actionable feedback in real-time, distinguishing it from other AI solutions.

Survey by AskX seamlessly integrates with Amplity’s established lineup of medical and commercial solutions, further solidifying Amplity Health’s role as a leading global medical and commercial partner for pharmaceutical and biopharmaceutical companies. The platform extends its capabilities to explore patient journeys and healthcare professional interactions through AI-powered search channels, indexing millions of qualitative data points from unstructured, real-world medical transcription records.

While AstraZeneca embarks on AI-powered antibody-based drug discovery, Amplity Health continues to push the boundaries of innovation, offering actionable insights through cutting-edge healthcare data solutions. Joe Turner emphasized Survey as a natural and powerful extension of the Amplity Insights ecosystem, reinforcing Amplity Health’s commitment to providing transformational yet easy-to-navigate healthcare data.

Related posts:

Sterile Dosage Form Market Anticipated to Reach US$ 1.1 Billion by 2033, Driven by Rising Demand for Infection-Free Medical Products | Future Market Insights, Inc. Teva Secures Early Launch of Generic Vivitrol After Settling Patent Case with Alkermes Novo Nordisk Invests $60 Million in Valo Health for AI-Powered Drug Discovery Polaris Market Research Unveils Extensive Report on the “Green Food Supplements Market” Offering In-Depth Insights